Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Balance2Perform IVS
IVS
In liquidation
CVR 38252313
Tovelillevej 61B
Sundhedsvæsen i øvrigt i.a.n. · NACE 869090
Est. 2016
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2019
DKK 152K
-517% vs 2018
EBITDA margin
78.8%
+429% vs 2018
Equity ratio
28.5%
Financial strength
Net profit 2019
DKK 82K
+317% vs 2018
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2017
0M
0%
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
DKK 152K
-517%
EBITDA
DKK 120K
+429%
Net profit
DKK 82K
+317%
Total assets
DKK 144K
-22%
Equity
DKK 41K
+201%
Employees
1
—
Company information
Legal name
Balance2Perform IVS
CVR number
38252313
Legal form
Iværksætterselskab
NACE code
869090 · Sundhedsvæsen i øvrigt i.a.n.
Founded
13. december 2016
Share capital
DKK 10.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Tovelillevej 61B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Sundhedsvæsen i øvrigt i.a.n.
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
Income statement
DKK thousands
Item
2017
2018
2019
Revenue
239
-36
152
Staff expenses
-0
-0
-32
EBITDA
-13
-36
120
Depreciation & amort.
-0
-1
-6
EBIT
-13
-38
114
Net financials
0
0
-5
Profit before tax
-13
-38
109
Tax
-0
-0
27
Net profit
-13
-38
82
Balance sheet
DKK thousands
Item
2017
2018
2019
Total assets
134
183
144
Equity
-3
-41
41
Long-term debt
0
0
0
Short-term debt
137
224
102
Total debt
137
224
102
Financial ratios
5-year trend
EBITDA margin
78.8%
This company
15.8%
Market median
+399% vs market
2017
2019
Equity ratio
28.5%
This company
38.2%
Market median
-25% vs market
2017
2019
Return on equity
199.3%
This company
18.4%
Market median
+983% vs market
2017
2019
Net profit margin
53.7%
This company
8.1%
Market median
+563% vs market
2017
2019
Asset turnover
1.06×
This company
1.12×
Market median
+5% vs market
2017
2019
Debt / equity
2.51×
This company
0.62×
Market median
-305% vs market
2017
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-12-13 – 2017-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (3)
EM
Emilla Møller-Petersen
Chief Executive Officer
Chief Executive Officer
2016 – 2017
AG
Anita Gawecka
Chief Executive Officer
Chief Executive Officer
2018 – 2018
DZ
Djalaluddin Zaferan
Chief Executive Officer
Chief Executive Officer
2017 – 2018
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Robert Petersen
Individual
100%
100%
2016
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Balance2Perform IVS also hold positions in
0
other companies.
Person
Role here
Other companies
Emilla Møller-Petersen
Chief Executive Officer
0 companies
Anita Gawecka
Chief Executive Officer
0 companies
Djalaluddin Zaferan
Chief Executive Officer
0 companies